USC-Brookings Schaeffer Initiative for Health Policy
Other featured articles
The Use of Vendors in Medicare Part B Drug Payment
USC-Brookings Schaeffer Initiative experts provide an analysis of a voluntary vendor approach for Medicare to restrain drug spending for Part B drugs.
Rep. Ruiz’s Arbitration Proposal For Surprise Billing (H.R. 3502) Would Lead To Much Higher Costs And Deficits
USC-Brookings Schaeffer Initiative researchers review the latest proposed legislation from Representative Ruiz on surprise medical billing.
CMS’s International Pricing Model for Medicare Part B Drugs: Implementation Issues
To lower the Part B portion of drug spending, the Trump Administration has proposed a demonstration project tying Medicare reimbursement for outpatient, physician-administered drugs to international prices. Paul Ginsburg and Steven Lieberman explore the potential consequences of such a rule.
We Need More Primary Care Physicians: Here’s Why and How
USC-Brookings Schaeffer Initiative researchers explain why we need more primary care physicians and how to close the gap between primary care and specialty medicine.
About this section
The Initiative is a partnership between the Center for Health Policy at Brookings and the USC Schaeffer Center for Health Policy & Economics, and aims to inform the national health care debate with rigorous, evidence-based analysis leading to practical recommendations using the collaborative strengths of USC and Brookings.